Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$907M |
| 2 |
Apple
AAPL
|
+$260M |
| 3 |
Microsoft
MSFT
|
+$223M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$471M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$177M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$160M |
| 4 |
Petrobras
PBR
|
+$153M |
| 5 |
Adobe
ADBE
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.79% |
| 2 | Healthcare | 12.41% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Public Service Enterprise Group
PEG
$38B
| $280K | ﹤0.01% |
4,421
-747
| -14% | -$50.8K |
|
727
Chubb
CB
$134B
| $279K | ﹤0.01% |
1,416
+93
| +7% | +$19.2K |
|
728
CBRE Group
CBRE
$43.4B
| $278K | ﹤0.01% |
3,779
+881
| +30% | +$70.9K |
|
729
Aecom
ACM
$9.68B
| $277K | ﹤0.01% |
4,247
-189
| -4% | -$13.2K |
|
730
Vanguard Morningstar Mega Cap ETF
MGC
$10.3B
| $276K | ﹤0.01% |
2,092
-244
| -10% | -$34.9K |
|
731
National Grid
NGG
$80.7B
| $276K | ﹤0.01% |
4,602
-327
| -7% | -$21.6K |
|
732
Enbridge
ENB
$117B
| $275K | ﹤0.01% |
6,507
-14,298
| -69% | -$638K |
|
733
iShares Russell Top 200 Value ETF
IWX
$4.05B
| $272K | ﹤0.01% |
+4,398
| New | +$290K |
|
734
TJX Companies
TJX
$175B
| $272K | ﹤0.01% |
4,863
+163
| +3% | +$9.87K |
|
735
Vanguard Health Care ETF
VHT
$18.1B
| $270K | ﹤0.01% |
1,147
-68
| -6% | -$16.4K |
|
736
iShares US Treasury Bond ETF
GOVT
$43.6B
| $267K | ﹤0.01% |
11,151
+2,318
| +26% | +$55.8K |
|
737
iShares Core Universal USD Bond ETF
IUSB
$43.1B
| $267K | ﹤0.01% |
5,696
-312
| -5% | -$14.8K |
|
738
Zoetis
ZTS
$31.7B
| $266K | ﹤0.01% |
1,548
+272
| +21% | +$47K |
|
739
American Electric Power
AEP
$70B
| $265K | ﹤0.01% |
2,764
-800
| -22% | -$79.3K |
|
740
Elevance Health
ELV
$82.7B
| $265K | ﹤0.01% |
548
-61
| -10% | -$30.2K |
|
741
Manulife Financial
MFC
$74.2B
| $263K | ﹤0.01% |
+15,182
| New | +$287K |
|
742
Schwab International Equity ETF
SCHF
$68B
| $263K | ﹤0.01% |
16,738
-21,592
| -56% | -$368K |
|
743
McKesson
MCK
$97.2B
| $261K | ﹤0.01% |
800
-162
| -17% | -$51.8K |
|
744
S&P Global
SPGI
$122B
| $260K | ﹤0.01% |
770
+66
| +9% | +$23.5K |
|
745
Keysight
KEYS
$58.4B
| $257K | ﹤0.01% |
+1,865
| New | +$265K |
|
746
Cincinnati Financial
CINF
$27.4B
| $253K | ﹤0.01% |
2,127
-34
| -2% | -$4.32K |
|
747
Ameren
AEE
$30.4B
| $252K | ﹤0.01% |
2,789
-10
| -0.4% | -$926 |
|
748
Motorola Solutions
MSI
$73.9B
| $252K | ﹤0.01% |
1,204
-2,020
| -63% | -$440K |
|
|
BNY
749
Bank of New York Mellon
BNY
$107B
| $251K | ﹤0.01% |
6,023
-1,321
| -18% | -$58.8K |
|
750
Smith & Nephew
SNN
$12.8B
| $251K | ﹤0.01% |
9,006
-9
| -0.1% | -$280 |
|
Similar funds
Ken Fisher's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Fisher held 1,196 positions worth $141B, down 17% from $169B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Fisher's Q2 2022 filing shows 110 new, 483 increased, 318 reduced and 131 closed positions. Its largest new stake was Woodside Energy: 6,156,348 shares worth $133M. The largest sale was Eli Lilly, an estimated $471M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Ken Fisher's largest Q2 2022 buy was Woodside Energy: 6,156,348 shares worth $133M.
- Ken Fisher added most to Johnson & Johnson in Q2 2022, an estimated $907M increase.
- Ken Fisher's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $471M.
- Ken Fisher fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $160M.
- Ken Fisher's ten largest holdings make up 30% of its $141B portfolio in Q2 2022.
- Ken Fisher opened 110 new positions and closed 131 in Q2 2022.
- Ken Fisher's portfolio value fell 17% quarter-over-quarter to $141B.
Based on Fisher Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.